StephenJamesSimkoIIIMD
Pediatric Hematology & Oncology • Palo Alto, CAPediatric Hematologic Oncology
Senior Medical Director, Genentech; Adjunct Clinical Assistant Professor, Lucile Packard Children's Hospital/Stanford University
Dr. Simko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
725 Welch Rd
Palo Alto, CA 94304- Is this information wrong?
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2008 - 2011
University of ColoradoResidency, Pediatrics, 2004 - 2007
Medical College of Georgia at Augusta UniversityClass of 2004
Certifications & Licensure
CA State Medical License 2015 - 2025
TX State Medical License 2011 - 2015
OH State Medical License 2007 - 2010
CO State Medical License 2006 - 2009- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations Start of enrollment: 2013 Jan 01
- Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies Start of enrollment: 2013 Jan 01
- Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors Start of enrollment: 2016 May 20
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsPaediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medi...Andrew D.J. Pearson, C. Michel Zwaan, E. Anders Kolb, Dominik Karres, Julie Guillot, Su Young Kim, Lynley V. Marshall, Sarah K. Tasian, Malcolm A. Smith, Todd M. Coope...> ;European Journal of Cancer. 2020 Sep 1
- 26 citationsBRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma.Julia C. Chisholm, Jozef Suvada, Ira J. Dunkel, Michela Casanova, Weijiang Zhang, Natasha Ritchie, YounJeong Choi, Jane Park, Meghna Das Thakur, Stephen J. Simko, Nga ...> ;Pediatric Blood & Cancer. 2018 May 1
- 37 citationsRare Pediatric Non‐Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1Chibuzo O'Suoji, Jennifer J.G. Welch, Sherrie L. Perkins, Lynette M. Smith, Sheila Weitzman, Stephen J. Simko, Paul J. Galardy, Catherine M. Bollard, Thomas G. Gross, ...> ;Pediatric Blood & Cancer. 2016 May 1
- Join now to see all
Hospital Affiliations
Lucile Packard Children's Hospital StanfordPalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
